Tech Company Financing Transactions
Enable Medicine Funding Round
On 4/6/2022, Enable Medicine raised $60 million in Series A funding from Anthos Capital, General Catalyst Partners and Axial.
Transaction Overview
Company Name
Announced On
4/6/2022
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series A
Investors
Anthos Capital (Lead Investor)
General Catalyst Partners (Lead Investor)
Proceeds Purpose
Proceeds purpose were not disclosed
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Menlo Park, CA Undisclosed
United States
Menlo Park, CA Undisclosed
United States
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We are on the forefront of decoding biology
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 4/6/2022: Coro venture capital transaction
Next: 4/6/2022: ReadySet Technology venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs